Prof. Jill Kolesar University of Kentucky, USA

Dr. Jill Kolesar is Professor of Pharmacy at the University of Kentucky and holds administrative positions at the Markey Cancer Center as the Director of the Early Phase Clinical Trials Center, Co-Chair of the Molecular Tumor Board, and the Co-Leader of the Developmental Therapeutics Program. Jill received her BS in... read morepharmacy at the University of Wisconsin and her Doctor of Pharmacy degree at the University of Texas Health Science Center in San Antonio, where she also completed a specialty practice residency in oncology/hematology and a fellowship in molecular oncology pharmacotherapy. She received an MS in Epidemiology with an emphasis in Genetic Epidemiology from the University of Wisconsin in 2016. After 15 years as a clinical pharmacist in the hematology clinic at Madison’s VA hospital, Dr. Kolesar transitioned her clinical practice to the UW Comprehensive Cancer Center where she co-chaired the Molecular Tumor Board, a multi-disciplinary group that reviews somatic mutations and recommends therapy targeted to those mutations for patients with cancer. Her research focuses on the drug development of anticancer agents with an emphasis on targeted therapies and biomarkers. She has authored more than 200 abstracts, research articles, and book chapters, and as a principal investigator she has received more than $1.5 million in research funding from the NCI, American Cancer Society and other sources. Jill has received teaching and research awards from local, national and international organizations including the Innovations in Teaching Award from the American Association of Colleges of Pharmacy.